��������

Marc Morris, MD JD has a diverse work experience in the field of drug safety and pharmacovigilance. Marc is currently serving as the Vice President of Drug Safety & Pharmacovigilance at Avidity Biosciences, Inc. Prior to this role, they held the same position at Sierra Oncology from 2020 to 2023. In 2019, they worked as the Vice President of Safety & Pharmacovigilance at Apellis Pharmaceuticals. From 2016 to 2019, they served as the Senior Director of Drug Safety & Pharmacovigilance at BeiGene. Before that, they worked at GSK as a Safety Development Leader and Medical Director from 2007 to 2016. From 2005 to 2007, they held the position of Medical Director at Inotek Pharmaceuticals Corporation, and from 2001 to 2005, they worked as an Associate Medical Director at Roche.

Marc Morris, MD JD received their Bachelor of Science degree in Biochemistry from the University of London. Marc then pursued a Master of Science degree in Pharmaceutical Medicine from the University of Surrey. Marc later earned a Doctor of Medicine (MD) degree from UCL. Finally, they obtained a Doctor of Law (JD) degree from Temple University - James E. Beasley School of Law.